ArticleCancers2023

MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial-Mesenchymal Transition (EMT) Pathways.

Yuntao Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.